EXPLORE THE SCIENCE
Caffeinated Coffee Linked to Lower Dementia Risk Over 43 Years TL;DR: Caffeinated coffee drinkers had 141 vs 330 dementia cases per 100,000 person-years in the highest versus lowest intake quartiles — across 131,821 adults followed up to 43 years. Decaf showed…
Read article
Broken Blood Vessels May Drive Alzheimer’s Decline TL;DR: A new study reveals that impaired cerebrovascular function—the brain’s ability to regulate blood flow—correlates strongly with Alzheimer’s symptoms, offering a potential non-invasive way to detect early…
Read article
How Lecanemab Clears Brain Amyloid: The Microglia Key TL;DR: Lecanemab, the first Alzheimer’s antibody to slow cognitive decline, works by activating immune cells called microglia through a specific immune signaling pathway, with the molecule SPP1/osteopontin…
Read article
Cell-Type Gene Networks Reveal Hidden Causes of Alzheimer’s TL;DR: Researchers mapped how genes are regulated differently across six brain cell types in Alzheimer’s disease, discovering that excitatory neurons drive the most extensive regulatory disruptions—an…
Read article
The Broken Repair Crew: How TDP43 Sabotages Genome Stability TL;DR: TDP43, the protein that misfires in ALS and FTD, secretly controls DNA repair genes—and when it breaks, mutations pile up in neurons, potentially explaining both neurodegeneration and the canc…
Read article
Blood Test Detects Alzheimer’s with 83% Accuracy TL;DR: A new blood test using three misfolded plasma proteins can identify Alzheimer’s disease with 83.44% accuracy, outperforming conventional biomarkers and offering a non-invasive screening tool years before…
Read article
Women experiencing midlife stress-related exhaustion have a higher risk of developing dementia at a younger age and exhibit long-term cognitive impairments. Highlights: Higher Dementia Risk: Women with midlife stress-related exhaustion had a nearly threefold i…
Read article
Lecanemab shows promise in treating Alzheimer’s disease by reducing clinical deterioration and amyloid-beta plaques, but it has significant adverse effects and requires further research for confirmation. Highlights: FDA Approval: The US FDA authorized lecanema…
Read article
TLDR: Herpes zoster vaccination is linked to a lower risk of dementia, but more studies are needed to confirm this association. Highlights: Five high-quality studies involving 103,615 vaccinated patients were analyzed. Herpes zoster vaccination was associated…
Read article
TLDR: GLP-1 agonists were found to significantly reduce the risk of dementia in older individuals with type 2 diabetes mellitus (T2DM) compared to DPP-4 inhibitors and sulfonylureas. Highlights: A sequential trial emulation was conducted using data from Swedis…
Read article